Checkpoint Inhibitor Associated Diabetes Mellitus: Early Recognition and Treatment (CERT) Project: A Pilot Study

NCT07257068 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Checkpoint Inhibitor
Pilot Study
Diabetes Melletus

Interventions

OTHER: Infliximab

Sponsor

M.D. Anderson Cancer Center